Home › Funds › Stonepine Capital Management, LLC › CAMP
Stonepine Capital Management, LLC position in CAMP
CAMP4 THERAPEUTICS CORP · Health Care
Stonepine Capital Management, LLC reported holding 2,786,249 shares of CAMP (CAMP4 THERAPEUTICS CORP) in its Q3 2026 13F filing — a position valued at US$11.3M, representing 8.64% of its reported portfolio and ranking #2 among its reported holdings. Stonepine Capital Management, LLC has disclosed CAMP holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Stonepine Capital Management, LLC's CAMP position evolved
Stonepine Capital Management, LLC first disclosed a stake in CAMP in Q4 2025 at 228,894 shares (US$1.4M). The position peaked in Q3 2026 at 2,786,249 shares, worth US$11.3M. Across 4 filings, Stonepine Capital Management, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 2,786,249 shares valued at US$11.3M — an increase of 1,396,627 shares quarter over quarter.. Notable position changes include a 507% increase in Q1 2026 (shares were roughly flat over the following quarter), a 101% increase in Q3 2026 (shares fell 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 228.89K | $1.40M | New |
| Q1 2026 | 1.39M | $6.13M | Add |
| Q2 2026 | 1.39M | $6.07M | Hold |
| Q3 2026 | 2.79M | $11.26M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CAMP and 13F data
CAMP (CAMP4 THERAPEUTICS CORP) is a Health Care company. 37 other funds we track also report a position in CAMP — the largest reported positions include 5AM Venture Management, LLC (US$25.6M), Vivo Capital, LLC (US$22.6M), a16z Capital Management, L.L.C. (US$9.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CAMP
- 5AM Venture Management, LLC 5.87M sh · $25.65M · Q2 2026
- Vivo Capital, LLC 5.58M sh · $22.56M · Q3 2026
- a16z Capital Management, L.L.C. 2.13M sh · $9.29M · Q2 2026
- Trails Edge Capital Partners, LP 1.93M sh · $8.45M · Q2 2026
- Enavate Sciences GP, LLC 1.43M sh · $6.23M · Q2 2026
- HARBOURVEST PARTNERS LLC 1.27M sh · $5.56M · Q2 2026
- Birchview Capital, LP 120.00K sh · $484.80K · Q3 2026
More on Stonepine Capital Management, LLC
FAQ
How long has Stonepine Capital Management, LLC held CAMP?
Stonepine Capital Management, LLC has disclosed CAMP holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Stonepine Capital Management, LLC's current position in CAMP?
As of Q3 2026, Stonepine Capital Management, LLC holds 2.79M shares of CAMP (CAMP4 THERAPEUTICS CORP), valued at $11.26M, representing 8.64% of its reported portfolio and ranking #2.
Has Stonepine Capital Management, LLC been buying or selling CAMP?
In the latest 13F filing (Q3 2026), Stonepine Capital Management, LLC increased its position in CAMP. The position peaked in Q3 2026 at 2.79M shares.
Which other funds hold CAMP?
Other major institutional holders of CAMP include 5AM Venture Management, LLC, Vivo Capital, LLC, a16z Capital Management, L.L.C., among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.